Microfluidic Fabrication of Hyaluronic Acid–Cysteine-Modified Chitosan Microspheres for CD44-Targeted Probiotic Delivery in Colitis Treatment
ACS Applied Materials & Interfaces · 23.07.2025 · 17 (29) · 41852-41867
DOI: 10.1021/acsami.5c10456 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, online erschienen am 12.07.2025. Verfasst von Fengzhi Qiao und 13 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Marine Food Processing & Safety Control, College of Food Science and Engineering, Ocean University of China, Qingdao 266003, …. Hauptthemen laut MEDLINE: Hyaluronic Acid, Chitosan, Colitis, Probiotics. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: Taishan Industry Leading Talents, China Postdoctoral Science Foundation, Ocean University of China.
Abstract (Originalsprache)
Probiotics play a crucial role in regulating intestinal immune homeostasis and supporting gut health; however, oral administration faces challenges such as nonspecific distribution and low efficacy. To achieve precise and efficient delivery, in this study, a targeted delivery system embedded probiotics to the colonic inflammatory site CD44 was constructed by covalently linking hyaluronic acid (HA) to cysteine-modified chitosan (CCH) using microfluidic technology. Two probiotic strains, Bifidobacterium bifidum FL-276.1 and Clostridium butyricum ATCC 19398, were encapsulated within the modified chitosan matrix to form probiotics@CCH microspheres (MSs), with an average diameter of approximately 276 μm. Based on the receptor–ligand binding mechanism of HA and CD44, combined with the intestinal mucosal adhesion properties conferred by cysteine-modified chitosan, the probiotics@CCH MSs exhibited a high capture rate for inflammatory Caco-2 cells and demonstrated prolonged retention and targeted localization in a DSS-induced colitis mouse model. Furthermore, probiotics@CCH MSs contributed to maintaining intestinal homeostasis by modulating gut microbiota composition, enhancing short-chain fatty acid production, and supporting the intestinal barrier integrity. The microfluidic-based delivery system facilitates the precise localization of probiotics within the intestine, providing a theoretical basis for enhancing probiotic applications in gut health management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Marine Food Processing & Safety Control, College of Food Science and Engineering, Ocean University of China, Qingdao 266003, China.
- Division of Gastrointestinal and Oncologic Surgery, Department of Surgery, Massachusetts General Hospital, Boston, Massachusetts 02114, United States.
- Qingdao Vland Biotech Group Co., Ltd., Qingdao 266006, China.
- Department of Stem Cell Research and Regenerative Medicine, School of Medicine, Stanford University, Stanford, California 94305, United States.
- Department of Medicinal Chemistry, Key Laboratory of Chemical Biology, School of Pharmacy, Cheeloo College of Medicine, Shandong University, Jinan, Shandong 250012, China.
ORCID-Profile: Shaolei Wang, Huaxi Yi, Guanhua Xuan, Xiangzhao Mao, Zhao Ma, Lanwei Zhang, Kai Lin
Förderung
- Taishan Industry Leading Talents
- China Postdoctoral Science Foundation
- Ocean University of China
- National Natural Science Foundation of China
- Key Technology Research and Development Program of Shandong Province
- Shandong Province
Zitieren
APA
Qiao, F., Luo, Y., Lei, P., Wang, S., Duan, Z., Cui, H., Liu, T., Yi, H., De Souza, C., Xuan, G., Mao, X., Ma, Z., Zhang, L., & Lin, K. (2025). Microfluidic Fabrication of Hyaluronic Acid–Cysteine-Modified Chitosan Microspheres for CD44-Targeted Probiotic Delivery in Colitis Treatment. ACS Applied Materials & Interfaces, 17(29), 41852-41867. https://doi.org/10.1021/acsami.5c10456
Vancouver
Qiao F, Luo Y, Lei P, Wang S, Duan Z, Cui H, et al. Microfluidic Fabrication of Hyaluronic Acid–Cysteine-Modified Chitosan Microspheres for CD44-Targeted Probiotic Delivery in Colitis Treatment. ACS Applied Materials & Interfaces. 2025;17(29):41852-41867. doi:10.1021/acsami.5c10456
BibTeX
@article{Qiao2025,
author = {Qiao, Fengzhi and Luo, Ya and Lei, Peng and Wang, Shaolei and Duan, Zhi and Cui, Hongchang and Liu, Tongjie and Yi, Huaxi and De Souza, Cristabelle and Xuan, Guanhua and Mao, Xiangzhao and Ma, Zhao and Zhang, Lanwei and Lin, Kai},
title = {Microfluidic Fabrication of Hyaluronic Acid–Cysteine-Modified Chitosan Microspheres for CD44-Targeted Probiotic Delivery in Colitis Treatment},
journal = {ACS Applied Materials & Interfaces},
year = {2025},
volume = {17},
number = {29},
pages = {41852--41867},
doi = {10.1021/acsami.5c10456}
}
EUVIMED